Aligato, Jay-ar P.
HRN: 22-07-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFUROXIME 750MG (VIAL)
10/18/2022
10/25/2022
IV
290 Mg
Q8
AGE With Severe Dehydration;RO UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes